Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesion...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	D'Haens, G, Fedorak, R, Lémann, M, Feagan, BG, Kamm, M, Cosnes, J, Rutgeerts, P, Marteau, P, Travis, S, Schölmerich, J, Hanauer, S, Sandborn, W
Format:	Journal article
Sprog:	English
Udgivet:	2009

Lignende værker

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
af: Gottlieb, K, et al.
Udgivet: (2015)

Evolving concepts in phases I and II drug development for Crohn's Disease
af: Jairath, V, et al.
Udgivet: (2016)

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
af: Peyrin-Biroulet, L, et al.
Udgivet: (2012)

Development of the Crohn's disease digestive damage score, the Lemann score.
af: Pariente, B, et al.
Udgivet: (2011)

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
af: Gasche, C, et al.
Udgivet: (2000)

Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
af: Jairath, V, et al.
Udgivet: (2016)

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
af: Clark, M, et al.
Udgivet: (2007)

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
af: Sandborn, W, et al.
Udgivet: (2016)

The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
af: Travis, S, et al.
Udgivet: (2012)

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
af: Travis, S, et al.
Udgivet: (2006)

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
af: Reinisch, W, et al.
Udgivet: (2018)

Management of Perianal Crohn's Disease
af: Paul Rutgeerts
Udgivet: (2000-01-01)

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
af: Danese, S, et al.
Udgivet: (2015)

Steroid-Dependent Crohn’s Disease
af: William J Sandborn
Udgivet: (2000-01-01)

Infliximab in the Treatment of Crohn’s Disease
af: Brian Feagan
Udgivet: (2000-01-01)

Characterization of Mucosal Lesions in Crohn's Disease Scored With Capsule Endoscopy: A Systematic Review
af: Miquel Marquès Camí, et al.
Udgivet: (2021-01-01)

Standardizing scoring conventions for Crohn’s disease endoscopy: An international RAND/UCLA appropriateness study
af: Khanna, R, et al.
Udgivet: (2023)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
af: Colombel, J, et al.
Udgivet: (2017)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn's disease
af: Jairath, V, et al.
Udgivet: (2016)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
af: Travis, S, et al.
Udgivet: (2012)

Biosimilars in IBD: hope or expectation?
af: Gecse, K, et al.
Udgivet: (2013)

Risk Factors for Relapse and Recurrence of Ulcerative Colitis and Crohn’s Disease
af: Paul Rutgeerts
Udgivet: (1993-01-01)

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
af: Samaan, MA, et al.
Udgivet: (2018)

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment
af: Remo Panaccione, et al.
Udgivet: (2015-12-01)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
af: D'Haens, G, et al.
Udgivet: (2011)

Osteoporosis of Crohn’s Disease: A Critical Review
af: Neena S Abraham, et al.
Udgivet: (1996-01-01)

Oropharyngeal Crohn&rsquo;s disease
af: Rachid Mohamed, et al.
Udgivet: (2008-12-01)

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
af: Panaccione, R, et al.
Udgivet: (2019)

Central Endoscopy Reading in Inflammatory Bowel Diseases
af: Panés, J, et al.
Udgivet: (2016)

Misleading pustular plaques of the lower limbs during Crohn's disease: two case reports
af: Farhi David, et al.
Udgivet: (2007-10-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
af: Neeraj Narula, et al.
Udgivet: (2009-01-01)

European evidence-based Consensus on the management of ulcerative colitis: Current management.
af: Travis, S, et al.
Udgivet: (2008)

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
af: Travis, S, et al.
Udgivet: (2013)

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
af: Travis, S, et al.
Udgivet: (2015)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
af: Van Assche, G, et al.
Udgivet: (2010)

Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms.
af: Camille Jung, et al.
Udgivet: (2012-01-01)

Predicting, Treating and Preventing Postoperative Recurrence of Crohn’s Disease: The State of the Field
af: Anna M Borowiec, et al.
Udgivet: (2011-01-01)

Crohn’s disease or Crohn’s diseases?
af: Arnott, IDR, et al.
Udgivet: (2003)

The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes?
af: De Silva, A, et al.
Udgivet: (2002)

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
af: Jessica R de Bruyn, et al.
Udgivet: (2018-01-01)